$1.29 Billion is the total value of NEA Management Company, LLC's 46 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 18.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| COUR | COURSERA INC | $240,498,602 | +43.5% | 12,867,769 | 0.0% | 18.57% | +45.2% | |
| ARCELLX INC | $134,380,001 | +13.5% | 3,745,262 | 0.0% | 10.38% | +14.8% | ||
| SVRA | Buy | SAVARA INC | $92,501,378 | +19.9% | 24,471,264 | +1.4% | 7.14% | +21.4% |
| VRNA | VERONA PHARMA PLCsponsered ads | $91,031,474 | -22.9% | 5,108,563 | 0.0% | 7.03% | -22.0% | |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $72,072,693 | -19.1% | 1,587,854 | 0.0% | 5.57% | -18.2% | |
| MIRM | MIRUM PHARMACEUTICALS INC | $69,085,279 | +22.1% | 2,186,243 | 0.0% | 5.34% | +23.6% | |
| RYTM | RHYTHM PHARMACEUTICALS INC | $66,710,741 | +39.0% | 2,909,956 | 0.0% | 5.15% | +40.6% | |
| GERN | Buy | GERON CORP | $48,285,987 | -29.5% | 22,776,409 | +6.7% | 3.73% | -28.7% |
| NEXTNAV INC | $42,092,262 | +74.8% | 8,189,156 | 0.0% | 3.25% | +76.9% | ||
| GLUE | MONTE ROSA THERAPEUTICS INC | $36,846,107 | -30.1% | 7,692,298 | 0.0% | 2.85% | -29.2% | |
| RPHM | RENEO PHARMACEUTICALS INC | $36,441,537 | +29.0% | 4,785,494 | 0.0% | 2.81% | +30.5% | |
| CVRX | CVRX INC | $35,961,122 | -1.7% | 2,370,542 | 0.0% | 2.78% | -0.6% | |
| CELC | CELCUITY INC | $31,791,305 | +149.8% | 1,250,001 | 0.0% | 2.46% | +152.8% | |
| AUPH | AURINIA PHARMACEUTICALS INC | $30,845,610 | -19.7% | 3,969,834 | 0.0% | 2.38% | -18.8% | |
| New | SAGIMET BIOSCIENCES INC | $27,105,936 | – | 3,850,275 | +100.0% | 2.09% | – | |
| TRVI | TREVI THERAPEUTICS INC | $24,787,420 | -8.8% | 11,370,376 | 0.0% | 1.91% | -7.7% | |
| DM | DESKTOP METAL INC | $21,022,433 | -17.5% | 14,407,594 | 0.0% | 1.62% | -16.5% | |
| XFOR | X4 PHARMACEUTICALS INC | $16,335,604 | -43.8% | 14,986,793 | 0.0% | 1.26% | -43.1% | |
| BRIGHT HEALTH GROUP INC | $16,279,694 | -51.1% | 2,726,917 | 0.0% | 1.26% | -50.6% | ||
| ZEROFOX HLDGS INC | $15,885,837 | -12.1% | 18,068,513 | 0.0% | 1.23% | -11.0% | ||
| ALLK | ALLAKOS INC | $13,954,280 | -47.9% | 6,147,260 | 0.0% | 1.08% | -47.3% | |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $13,322,227 | -15.7% | 17,079,778 | 0.0% | 1.03% | -14.7% | |
| GOSS | Buy | GOSSAMER BIO INC | $13,098,230 | +214.8% | 15,727,942 | +353.6% | 1.01% | +218.2% |
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $12,767,933 | -43.2% | 4,448,757 | 0.0% | 0.99% | -42.5% | |
| PHAT | PHATHOM PHARMACEUTICALS INC | $12,238,290 | -33.1% | 1,276,595 | 0.0% | 0.94% | -32.3% | |
| CSBR | CHAMPIONS ONCOLOGY INC | $10,642,201 | -2.7% | 1,713,720 | 0.0% | 0.82% | -1.6% | |
| INZY | INOZYME PHARMA INC | $10,238,294 | -24.6% | 2,437,689 | 0.0% | 0.79% | -23.6% | |
| TUYA | TUYA INCsponsered ads | $7,648,692 | -18.0% | 4,934,640 | 0.0% | 0.59% | -17.0% | |
| GLYC | GLYCOMIMETICS INC | $7,146,660 | -13.8% | 4,764,440 | 0.0% | 0.55% | -12.8% | |
| IVA | INVENTIVA SAads | $6,346,161 | +7.4% | 1,462,586 | 0.0% | 0.49% | +8.6% | |
| BUZZFEED INC | $5,859,080 | -24.3% | 15,333,892 | 0.0% | 0.45% | -23.5% | ||
| MINERVA SURGICAL INC | $5,664,895 | -35.8% | 34,437,052 | 0.0% | 0.44% | -35.1% | ||
| NKTX | NKARTA INC | $4,960,606 | -36.5% | 3,568,781 | 0.0% | 0.38% | -35.8% | |
| MARKER THERAPEUTICS INC | $4,864,283 | +46.5% | 1,071,428 | 0.0% | 0.38% | +48.0% | ||
| Sell | ACRIVON THERAPEUTICS INC | $4,113,209 | -34.1% | 430,252 | -10.7% | 0.32% | -33.3% | |
| RGLS | REGULUS THERAPEUTICS INC | $2,665,443 | -6.8% | 1,945,579 | 0.0% | 0.21% | -5.5% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $2,596,692 | -52.4% | 2,382,286 | 0.0% | 0.20% | -51.7% | |
| AFMD | AFFIMED NV | $2,115,419 | -20.1% | 4,426,488 | 0.0% | 0.16% | -19.3% | |
| SENTI BIOSCIENCES INC | $1,828,000 | -34.1% | 4,426,151 | 0.0% | 0.14% | -33.5% | ||
| IKNA | New | IKENA ONCOLOGY INC | $707,200 | – | 181,473 | +100.0% | 0.06% | – |
| New | SYNLOGIC INC | $614,605 | – | 281,929 | +100.0% | 0.05% | – | |
| New | SURF AIR MOBILITY INC | $610,199 | – | 440,418 | +100.0% | 0.05% | – | |
| ADXN | ADDEX THERAPEUTICS LTDsponsored ads | $408,293 | -35.5% | 180,000 | 0.0% | 0.03% | -33.3% | |
| WHEELS UP EXPERIENCE INC | $219,679 | +76.9% | 106,126 | 0.0% | 0.02% | +88.9% | ||
| Sell | EARGO INC | $188,760 | -81.6% | 86,946 | -58.2% | 0.02% | -80.8% | |
| New | AKARI THERAPEUTICS PLCsponsored adr | $89,303 | – | 22,608 | +100.0% | 0.01% | – | |
| AKTX | Exit | AKARI THERAPEUTICS PLCsponsored adr | $0 | – | -452,167 | -100.0% | -0.01% | – |
| SYBX | Exit | SYNLOGIC INC | $0 | – | -4,228,940 | -100.0% | -0.14% | – |
| Exit | BERKSHIRE GREY INC | $0 | – | -38,183,023 | -100.0% | -4.11% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GLYCOMIMETICS INC | 39 | Q3 2023 | 7.6% |
| AURINIA PHARMACEUTICALS INC | 37 | Q3 2023 | 5.0% |
| CHAMPIONS ONCOLOGY INC | 33 | Q3 2023 | 1.2% |
| LEXICON PHARMACEUTICALS INC | 32 | Q3 2023 | 2.0% |
| ADAPTIMMUNE THERAPEUTICS PLC | 31 | Q3 2023 | 9.3% |
| TREVENA INC | 31 | Q3 2021 | 3.3% |
| AKARI THERAPEUTICS PLC | 31 | Q2 2023 | 0.3% |
| ARDELYX INC | 29 | Q3 2021 | 11.9% |
| RIGEL PHARMACEUTICALS INC | 29 | Q2 2020 | 0.6% |
| EPIZYME INC | 28 | Q1 2020 | 9.6% |
View NEA Management Company, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
View NEA Management Company, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.